v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Registered shares
Additional paid-in capital
Treasury shares
Retained earnings
Accumulated other comprehensive loss
Beginning of the period (in shares) at Mar. 31, 2023   173,106,000        
Beginning of the period (in shares) at Mar. 31, 2023       13,763,000    
Beginning of the period at Mar. 31, 2023 $ 2,257,560 $ 30,148 $ 127,380 $ (977,266) $ 3,177,575 $ (100,277)
Increase (Decrease) in Shareholders' Equity            
Total comprehensive income 601,218       612,143 (10,925)
Purchases of registered shares (in shares)       7,100,000    
Purchases of registered shares (523,751)     $ (523,751)    
Sale of shares upon exercise of stock options and purchase rights (in shares)       (624,000)    
Sale of shares upon exercise of stock options and purchase rights 32,197   (28,314) $ 60,511    
Issuance of shares upon vesting of restricted stock units (in shares)       (994,000)    
Issuance of shares upon vesting of restricted stock units (29,744)   (118,771) $ 89,027    
Issuance of shares related to contingent consideration (in shares)       (2,000)    
Issuance of shares related to contingent consideration 245   102 $ 143    
Share-based compensation 83,127   83,127      
Cash dividends (187,199)       (187,199)  
End of the period (in shares) at Mar. 31, 2024   173,106,000        
End of the period (in shares) at Mar. 31, 2024       19,243,000    
End of the period balance at Mar. 31, 2024 2,233,653 $ 30,148 63,524 $ (1,351,336) 3,602,519 (111,202)
Increase (Decrease) in Shareholders' Equity            
Total comprehensive income 595,779       631,529 (35,750)
Purchases of registered shares (in shares)       6,679,000    
Purchases of registered shares (588,028)     $ (588,028)    
Sale of shares upon exercise of stock options and purchase rights (in shares)       (492,000)    
Sale of shares upon exercise of stock options and purchase rights 36,405   (10,588) $ 52,927 (5,934)  
Issuance of shares upon vesting of restricted stock units (in shares)       (833,000)    
Issuance of shares upon vesting of restricted stock units (32,485)   (60,422) $ 89,437 (61,500)  
Cancellation of treasury shares (in shares)   (4,112,000)   (4,112,000)    
Cancellation of treasury shares 0 $ (716)   $ 332,088 (331,372)  
Share-based compensation 90,077   90,077      
Cash dividends $ (207,981)       (207,981)  
End of the period (in shares) at Mar. 31, 2025   168,994,000        
End of the period (in shares) at Mar. 31, 2025 20,485,000     20,485,000    
End of the period balance at Mar. 31, 2025 $ 2,127,420 $ 29,432 82,591 $ (1,464,912) 3,627,261 (146,952)
Increase (Decrease) in Shareholders' Equity            
Total comprehensive income 744,322       711,187 33,135
Purchases of registered shares (in shares)       6,167,000    
Purchases of registered shares (557,043)     $ (557,043)    
Sale of shares upon exercise of stock options and purchase rights (in shares)       (512,000)    
Sale of shares upon exercise of stock options and purchase rights 38,320   (5,256) $ 43,576    
Issuance of shares upon vesting of restricted stock units (in shares)       (648,000)    
Issuance of shares upon vesting of restricted stock units (21,438)   (66,491) $ 58,760 (13,707)  
Cancellation of treasury shares (in shares)   (8,210,000)   (8,210,000)    
Cancellation of treasury shares 0 $ (1,431)   $ 712,165 (710,734)  
Share-based compensation 112,542   112,542      
Cash dividends $ (232,729)       (232,729)  
End of the period (in shares) at Mar. 31, 2026   160,784,000        
End of the period (in shares) at Mar. 31, 2026 17,281,896     17,282,000    
End of the period balance at Mar. 31, 2026 $ 2,211,394 $ 28,001 $ 123,386 $ (1,207,454) $ 3,381,278 $ (113,817)